We recognize that WTO Members with insufficient or no manufacturing capacities in the pharmaceutical sector could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement.

• 我们认识到那些在医药领域没有或没有足够生产能力的WTO成员在有效使用。《与贸易有关的知识产权协定》中规定的强制许可时，可能遇到困难。